Canton Strategic Holdings (CNTN) EBT (2021 - 2026)
Canton Strategic Holdings (CNTN) reported EBT of -$51.6 million for Q1 2026, down 1928.7% on a YoY basis from $2.8 million in Q1 2025, and down 2121.27% quarter-over-quarter from -$2.3 million in Q4 2025.
Canton Strategic Holdings (CNTN) EBT (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported EBT for 6 years, with the latest figure at -$51.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 1928.7% year-over-year to -$51.6 million; the trailing twelve-month figure through Mar 2026 stood at -$57.8 million (down 364.62% YoY), and the FY2025 full-year result was -$42.1 million, down 245.18% from the prior year.
- EBT for Q1 2026 stood at -$51.6 million, down from -$2.3 million in the prior quarter.
- The five-year high for EBT was -$1.6 million in Q2 2022, with the low at -$51.6 million in Q1 2026.
- Historically, EBT has averaged -$5.3 million across 5 years, with a median of -$2.3 million in 2024.
- Annual changes were most pronounced in 2025 — EBT soared 44.63% — and 2026, when it slumped 1928.7%.
- Canton Strategic Holdings' EBT stood at -$1.8 million in 2022, then tumbled by 40.74% to -$2.5 million in 2023, then slumped by 53.08% to -$3.8 million in 2024, then jumped by 38.7% to -$2.3 million in 2025, then slumped by 2121.27% to -$51.6 million in 2026.
- The last three EBT figures came in at -$51.6 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -51.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.56 Mn |
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Mar 31, 2025 | -2.54 Mn |
| Dec 31, 2024 | -3.79 Mn |
| Sep 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -2.33 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Sep 30, 2023 | -1.82 Mn |
| Jun 30, 2023 | -2.34 Mn |
| Mar 31, 2023 | -2.69 Mn |
| Dec 31, 2022 | -1.76 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -2.95 Mn |
| Dec 31, 2021 | -359,593.00 |
| Sep 30, 2021 | -777,113.00 |
| Jun 30, 2021 | -1.29 Mn |